Auxly Cannabis Group Inc. (TSE:XLY) shares have continued their recent momentum with a 30% gain in the last month alone. The last 30 days were the cherry on top of the stock’s 333% gain in the last year, which is nothing short of spectacular.
In spite of the firm bounce in price, there still wouldn’t be many who think Auxly Cannabis Group’s price-to-sales (or “P/S”) ratio of 0.7x is worth a mention when the median P/S in Canada’s Pharmaceuticals industry is similar at about 0.8x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.
Check out our latest analysis for Auxly Cannabis Group
What Does Auxly Cannabis Group’s Recent Performance Look Like?
Auxly Cannabis Group has been doing a good job lately as it’s been growing revenue at a solid pace. …
